<SEC-DOCUMENT>0001104659-16-160414-index.html : 20161202
<SEC-HEADER>0001104659-16-160414.hdr.sgml : 20161202
<ACCEPTANCE-DATETIME>20161202160206
ACCESSION NUMBER:		0001104659-16-160414
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		12
FILED AS OF DATE:		20161202
DATE AS OF CHANGE:		20161202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celldex Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000744218
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				133191702
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-214882
		FILM NUMBER:		162031173

	BUSINESS ADDRESS:	
		STREET 1:		53 FRONTAGE ROAD
		STREET 2:		SUITE 220
		CITY:			HAMPTON
		STATE:			NJ
		ZIP:			08827
		BUSINESS PHONE:		908-200-7500

	MAIL ADDRESS:	
		STREET 1:		53 FRONTAGE ROAD
		STREET 2:		SUITE 220
		CITY:			HAMPTON
		STATE:			NJ
		ZIP:			08827

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AVANT IMMUNOTHERAPEUTICS INC
		DATE OF NAME CHANGE:	19980828

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	T CELL SCIENCES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>a16-22161_1s3.htm
<DESCRIPTION>S-3
<TEXT>
Document 1 - file: a16-22161_1s3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.10 <SEQUENCE>2 <FILENAME>a16-22161_1ex4d10.htm <DESCRIPTION>EX-4.10 <TEXT> Document 2 - file: a16-22161_1ex4d10.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>a16-22161_1ex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 3 - file: a16-22161_1ex5d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-12.1 <SEQUENCE>4 <FILENAME>a16-22161_1ex12d1.htm <DESCRIPTION>EX-12.1 <TEXT> Document 4 - file: a16-22161_1ex12d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>5 <FILENAME>a16-22161_1ex23d1.htm <DESCRIPTION>EX-23.1 <TEXT> Document 5 - file: a16-22161_1ex23d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g221611bwi001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g221611bwi001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>g221611bwi002.gif <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: g221611bwi002.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>g221611bei001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 8 - file: g221611bei001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>g221611kg01i001.gif <DESCRIPTION>GRAPHIC <TEXT> Document 9 - file: g221611kg01i001.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>10 <FILENAME>g221611kg03i001.gif <DESCRIPTION>GRAPHIC <TEXT> Document 10 - file: g221611kg03i001.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>11 <FILENAME>g221611bmi001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 11 - file: g221611bmi001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>12 <FILENAME>g221611bmi002.gif <DESCRIPTION>GRAPHIC <TEXT> Document 12 - file: g221611bmi002.gif
</DOCUMENT> </SEC-DOCUMENT>